249 related articles for article (PubMed ID: 23233170)
21. Effect of triptolide on aromatase activity in human placental microsomes and human placental JEG-3 cells.
Zhang J; Jiang Z; Zhang L
Arzneimittelforschung; 2011; 61(12):727-33. PubMed ID: 22282961
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
[TBL] [Abstract][Full Text] [Related]
23. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
24. Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.
Tao Y; Zhang ML; Ma PC; Sun JF; Zhou WQ; Cao YP; Li LJ
Asian Pac J Cancer Prev; 2012; 13(4):1611-5. PubMed ID: 22799376
[TBL] [Abstract][Full Text] [Related]
25. [Triptolide evaluates DNA methylation level of matrix metalloproteinase 9 gene in human fibrosarcoma HT-1080 cells].
Yang S; Wen H; Zhang G; Zhao S; Luo Y; Lu Q
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):611-4. PubMed ID: 19526795
[TBL] [Abstract][Full Text] [Related]
26. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
[TBL] [Abstract][Full Text] [Related]
27. Triptolide inhibits COX-2 expression by regulating mRNA stability in TNF-α-treated A549 cells.
Sun L; Zhang S; Jiang Z; Huang X; Wang T; Huang X; Li H; Zhang L
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):99-105. PubMed ID: 22093832
[TBL] [Abstract][Full Text] [Related]
28. [Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism].
Deng J; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):434-9. PubMed ID: 15972136
[TBL] [Abstract][Full Text] [Related]
29. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
30. Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells.
Tan BJ; Tan BH; Chiu GN
Oncol Rep; 2011 Nov; 26(5):1315-21. PubMed ID: 21805042
[TBL] [Abstract][Full Text] [Related]
31. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
32. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression.
Guo Q; Nan XX; Yang JR; Yi L; Liang BL; Wei YB; Zhu N; Hu SB; Zhang H; Luo Y; Xu YF
Neoplasma; 2013; 60(6):598-604. PubMed ID: 23906293
[TBL] [Abstract][Full Text] [Related]
33. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
Wan CK; Wang C; Cheung HY; Yang M; Fong WF
Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721
[TBL] [Abstract][Full Text] [Related]
34. Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM.
Peng Y; Woods RG; Beamish H; Ye R; Lees-Miller SP; Lavin MF; Bedford JS
Cancer Res; 2005 Mar; 65(5):1670-7. PubMed ID: 15753361
[TBL] [Abstract][Full Text] [Related]
35. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
36. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
[TBL] [Abstract][Full Text] [Related]
37. [Effects of triptolide on prostate carcinoma in mouse RM-1 cells].
Zhang R; Zhang PY; Guo J; Yang D; Wang WJ; Zheng MH; Ma YC
Zhonghua Nan Ke Xue; 2007 Mar; 13(3):237-41. PubMed ID: 17393788
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antitumor effect of combined triptolide and ionizing radiation.
Wang W; Yang S; Su Y; Xiao Z; Wang C; Li X; Lin L; Fenton BM; Paoni SF; Ding I; Keng P; Okunieff P; Zhang L
Clin Cancer Res; 2007 Aug; 13(16):4891-9. PubMed ID: 17699869
[TBL] [Abstract][Full Text] [Related]
39. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
Huang SM; Lu KT; Wang YC
Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
[TBL] [Abstract][Full Text] [Related]
40. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
Zhang Z; Sun C; Zhang L; Chi X; Ji J; Gao X; Wang Y; Zhao Z; Liu L; Cao X; Yang Y; Mao W
Biomed Pharmacother; 2019 Jan; 109():1541-1546. PubMed ID: 30551406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
